Enovis (ENOV) FCF Payout Ratio (2012 - 2013)
Enovis (ENOV) posted quarterly FCF Payout Ratio of 0.11 for Q3 2013, down 63.61% year-over-year from 0.31 in Q3 2012, and down 24.15% quarter-over-quarter from 0.15 in Q4 2012.
Enovis (ENOV) FCF Payout Ratio (2012 - 2013) Analysis & Trends
Enovis (ENOV) has reported FCF Payout Ratio for 2 consecutive years, with 0.11 the latest figure, recorded in Q3 2013.
- In Q3 2013, FCF Payout Ratio fell 63.61% year-over-year to 0.11; the TTM figure through Dec 2013 stood at 0.13 (down 59.45% YoY), while the FY2019 annual figure was 16.86, changed N/A from the prior year.
- FCF Payout Ratio retreated to 0.11 in Q3 2013 per ENOV's latest filing, from 0.15 in the prior quarter.
- Across five years, FCF Payout Ratio topped out at 0.31 in Q3 2012 and bottomed at 0.02 in Q2 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | 0.55 |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 0.32 |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 0.44 |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 0.24 |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | -0.73 |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 0.22 |
| 10 | Enovis | 1.52 Bn | 1.50 Bn | 359.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 27, 2013 | 0.11 |
| Dec 31, 2012 | 0.15 |
| Sep 28, 2012 | 0.31 |
| Jun 29, 2012 | -0.02 |
| Mar 30, 2012 | -0.02 |